Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other Accumulated Expenses (2016 - 2025)

Altimmune (ALT) has disclosed Other Accumulated Expenses for 8 consecutive years, with $315000.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 472.73% to $315000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $315000.0 through Dec 2025, up 472.73% year-over-year, with the annual reading at $315000.0 for FY2025, 472.73% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $315000.0 at Altimmune, up from $177000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $315000.0 in Q4 2025, with the low at $54000.0 in Q3 2024.
  • Average Other Accumulated Expenses over 4 years is $120200.0, with a median of $86000.0 recorded in 2022.
  • The sharpest move saw Other Accumulated Expenses crashed 55.65% in 2024, then soared 472.73% in 2025.
  • Over 4 years, Other Accumulated Expenses stood at $103000.0 in 2022, then rose by 20.39% to $124000.0 in 2023, then plummeted by 55.65% to $55000.0 in 2024, then skyrocketed by 472.73% to $315000.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $315000.0, $177000.0, and $183000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.